A Study to Assess Safety and Tolerability as Well as Absorption and Excretion of TC-5214 in Medically Stable Elderly Subjects

NCT01239771 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Elderly Subjects 65 Years and Older, Healthy or With a Stable Disease and Treatment.

Interventions

DRUG: TC-5214
DRUG: Placebo

Sponsor

AstraZeneca